Viewing Study NCT00718861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:45 AM
Ignite Modification Date: 2026-04-02 @ 11:35 AM
Study NCT ID: NCT00718861
Status: COMPLETED
Last Update Posted: 2014-10-09
First Post: 2008-07-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Post-menopausal Osteoporosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Osteoporosis View
None zoledronic acid View
None post-menopausal View